Humana Reports Fourth Quarter 2020 Financial Results; Provides Full Year 2021 Financial Guidance

Go back to Humana Reports Fourth Quarter 2020 Financial Results; Provides Full Year 2021 Financial Guidance

Humana (HUM) PT Raised to $450 at Cantor Fitzgerald

February 3, 2021 12:30 PM EST

Cantor Fitzgerald analyst Steven Halper raised the price target on Humana (NYSE: HUM) to $450.00 (from $440.00) while maintaining an Overweight rating.

The analyst commented, "We reiterate our OW rating on HUM and increase our price target to $450 from $440. On Wednesday, February 3, Humana reported better-than-expected 4Q20... More

Humana (HUM) Tops Q4 EPS by 6c, Offers FY21 Guidance

February 3, 2021 6:32 AM EST

Humana (NYSE: HUM) reported Q4 EPS of ($2.30), $0.06 better than the analyst estimate of ($2.36). Revenue for the quarter came in at $19.06 million versus the consensus estimate of $18.77 million.

GUIDANCE:

Humana sees FY2021 EPS of $21.25-$21.75, versus the consensus of $21.73.

For earnings history and earnings-related data on Humana (HUM) click here.

... More